Literature DB >> 4558132

[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].

B Gattringer, H Steinhäusl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4558132

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


× No keyword cloud information.
  2 in total

1.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

Review 2.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.